ArticleScience advances2022

Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL.

Zhiliang Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.